09-10-2010: Chiral Technologies Europe (CTE) announced that it has entered into an exclusive worldwide licensing agreement with the University of Vienna, Austria. According to the agreement, CTE acquired exclusive manufacturing and marketing rights for novel Cinchona alkaloid-based zwitterion-exchange type chiral stationary phases (CSPs), invented and developed by researchers at the University of Vienna. The addition of the new CSPs provides a significant expansion of Chiral Technologies’ well-established portfolio of enantioselective chromatography products.
“The opportunity to collaborate with Professor Lindner and his renowned research team at the University of Vienna on the commercialization of this new stationary phase fits nicely within our broader strategy to expand our position in supplying new chirality tools to the life science industry,” said Dieter Heckmann, President and CEO of CTE. “This licensing agreement demonstrates our continued commitment to deliver the best solutions to the global market.”
The zwitterion-exchange type CSPs separate a broad range of ionizable chiral analytes, ranging from acidic and basic molecules to zwitterionic molecules that bear basic and acidic moieties in the same molecule. It has been adapted for direct enantiomer resolution of natural and synthetic free a-, b-, g-amino acids without requiring pre-column derivatization. In addition, chiral zwitterionic peptides and peptomimetics can be separated into their respective stereoisomers. The new selectors can be used in liquid chromatography and supercritical fluid chromatography modes with mobile phases that are compatible with all LC/MS applications.
Chiral Technologies Europe (CTE) announced that it has entered into an exclusive worldwide licensing agreement with the University of Vienna, Austria. According to the agreement, CTE acquired exclusive manufacturing and marketing rights for novel Cinchona alkaloid-based zwitterion-exchange ... more
Chiral Technologies Europe announced it has signed a non-exclusive distribution agreement with Hichrom Ltd. to better serve its customers in the United Kingdom.
"We are pleased to formalise our relationship with Hichrom. The technical sales group of Hichrom are well placed to present the b ... more
Chiral Technologies Europe (CTE), a wholly owned subsidiary of DAICEL Chemical Industries, Ltd, announced the acquisition of ChromTech Ltd, of Congleton, U.K.
According to the company, the two companies’ combined product lines of enantioselective chromatography columns will provide a powe ... more
Just as a camera flash illuminates unseen objects hidden in darkness, a sequence of laser pulses can be used to study the elusive quantum behavior of a large "macroscopic" object. This method provides a novel tool of unprecedented performance for current experiments that push the boundaries ... more
When waves meet, a new single wave is created. This phenomenon is well understood for mechanical waves such as sound, and electro-magnetic waves such as light, and the "interference" of light waves is applied in astronomy, fiber optics, and oceanography. The observation that even individual ... more
Chiral Technologies Europe (CTE) announced that it has entered into an exclusive worldwide licensing agreement with the University of Vienna, Austria. According to the agreement, CTE acquired exclusive manufacturing and marketing rights for novel Cinchona alkaloid-based zwitterion-exchange ... more